← Evidence map

ArticleMolecular therapy. Oncology2025

CDCP1-targeting ADC outperforms standard therapies in Ras-mutant pancreatic cancer.

Yun Jung Um et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40800005